The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Treprostinil
Treprostinil · TREPROSTINIL 100 mg/20mL · Injection, Solution · Intravenous; Subcutaneous · Alembic Pharmaceuticals Inc.
NDC 62332-0516-20 · 1 VIAL in 1 CARTON / 20 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Corden Pharma SpaItalymanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $8,281.16 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA211574
- TE code
- AP
- Approval date
- Feb 11, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Treprostinil (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alembic Pharmaceuticals Inc. | TREPROSTINIL 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | TREPROSTINIL 20 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | TREPROSTINIL 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | TREPROSTINIL 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Inc., | TREPROSTINIL 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Inc., | TREPROSTINIL 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Inc., | TREPROSTINIL 20 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Inc., | TREPROSTINIL 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Parenteral Medicines, Inc. | TREPROSTINIL 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Parenteral Medicines, Inc. | TREPROSTINIL 20 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Parenteral Medicines, Inc. | TREPROSTINIL 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Parenteral Medicines, Inc. | TREPROSTINIL 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| United Therapeutics Corporation | TREPROSTINIL 8 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| United Therapeutics Corporation | TREPROSTINIL 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| United Therapeutics Corporation | TREPROSTINIL 20 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| United Therapeutics Corporation | TREPROSTINIL 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| United Therapeutics Corporation | TREPROSTINIL 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Treprostinil — NDC 62332-0516-20," retrieved September 3, 2026, https://drugdashboards.com/drug/62332051620.
Free to cite with attribution — see how the data is put together.